<Publication>
  <id>TUW-203924</id>
  <title>Towards an interoperable information infrastructure providing decision support for genomic medicine</title>
  <keywords/>
  <authors>
    <Author>
      <name>
Matthias SAMWALDa,b,1, Holger STENZHORNc, Michel DUMONTIERd, M. Scott
MARSHALLe,f, Joanne LUCIANOg,h, and Klaus-Peter ADLASSNIGi
</name>
      <firstNames/>
      <affiliations/>
    </Author>
    <Author>
      <name>Holger Michel M Joanne</name>
      <firstNames/>
      <affiliations/>
    </Author>
    <Author>
      <name>Klaus-Peter</name>
      <firstNames/>
      <affiliations/>
    </Author>
  </authors>
  <affiliations/>
  <sections>
    <Section>
      <title>
Introduction
</title>
      <type>introduction</type>
      <typeEnum>INTRODUCTION</typeEnum>
      <referenceIds/>
      <referenceCitations/>
    </Section>
    <Section>
      <title>
1 Corresponding Author.
</title>
      <type>method</type>
      <typeEnum>METHOD</typeEnum>
      <referenceIds/>
      <referenceCitations/>
    </Section>
    <Section>
      <title>
1. Methods
</title>
      <type>method</type>
      <typeEnum>METHOD</typeEnum>
      <referenceIds/>
      <referenceCitations/>
    </Section>
    <Section>
      <title>
2. Preliminary results and discussion
</title>
      <type>method</type>
      <typeEnum>METHOD</typeEnum>
      <referenceIds/>
      <referenceCitations/>
    </Section>
    <Section>
      <title>
References
</title>
      <type>references</type>
      <typeEnum>REFERENCES</typeEnum>
      <referenceIds/>
      <referenceCitations/>
    </Section>
  </sections>
  <citationContexts/>
  <references>
    <Reference>
      <marker>[1]</marker>
      <title>Genetic diversity and new therapeutic concepts“,</title>
      <authors>
        <ReferenceAuthor>
          <name>B S Shastry</name>
          <firstNames/>
        </ReferenceAuthor>
      </authors>
      <volume>50</volume>
      <publicationYear>2005</publicationYear>
    </Reference>
    <Reference>
      <marker>[2]</marker>
      <title>Pharmacogenomic Biomarker Information in Drug Labels Approved by the United States Food and Drug Administration: Prevalence of Related Drug Use“, Pharmacotherapy,</title>
      <authors>
        <ReferenceAuthor>
          <name>F W Frueh</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>S Amur</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>P Mummaneni</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>R S Epstein</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>R E Aubert</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>T M DeLuca</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>R R Verbrugge</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>G J Burckart</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>und L J Lesko</name>
          <firstNames/>
        </ReferenceAuthor>
      </authors>
      <volume>28</volume>
      <publicationYear>2008</publicationYear>
    </Reference>
    <Reference>
      <marker>[3]</marker>
      <title>Health Care and Life Sciences (HCLS) Interest Group“ Available:</title>
      <authors>
        <ReferenceAuthor>
          <name>„Semantic Web</name>
          <firstNames/>
        </ReferenceAuthor>
      </authors>
      <publicationYear>2001</publicationYear>
    </Reference>
    <Reference>
      <marker>[6]</marker>
      <title>The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge“,</title>
      <authors>
        <ReferenceAuthor>
          <name>T Hernandez-Boussard</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>M Whirl-Carrillo</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>J M Hebert</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>L Gong</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>R Owen</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>M Gong</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>W Gor</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>F Liu</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>C Truong</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>R Whaley</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>M Woon</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>T Zhou</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>R B Altman</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>und T E Klein</name>
          <firstNames/>
        </ReferenceAuthor>
      </authors>
      <volume>36</volume>
      <publicationYear>2008</publicationYear>
    </Reference>
    <Reference>
      <marker>[7]</marker>
      <title>DrugBank and its relevance to pharmacogenomics“,</title>
      <authors>
        <ReferenceAuthor>
          <name>D S Wishart</name>
          <firstNames/>
        </ReferenceAuthor>
      </authors>
      <volume>9</volume>
      <publicationYear>2008</publicationYear>
    </Reference>
    <Reference>
      <marker>[11]</marker>
      <title>Using text to build semantic networks for pharmacogenomics“,</title>
      <authors>
        <ReferenceAuthor>
          <name>A Coulet</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>N H Shah</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>Y Garten</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>M Musen</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>und R B Altman</name>
          <firstNames/>
        </ReferenceAuthor>
      </authors>
      <volume>43</volume>
      <publicationYear>2010</publicationYear>
    </Reference>
    <Reference>
      <marker>[12]</marker>
      <title>Horizon scanning for new genomic tests“,</title>
      <authors>
        <ReferenceAuthor>
          <name>M Gwinn</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>D A Grossniklaus</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>W Yu</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>S Melillo</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>A Wulf</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>J Flome</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>W D Dotson</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>und M J Khoury</name>
          <firstNames/>
        </ReferenceAuthor>
      </authors>
      <publicationYear>2011</publicationYear>
    </Reference>
    <Reference>
      <marker>[13]</marker>
      <source>The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group“,</source>
      <authors>
        <ReferenceAuthor>
          <name>S M Teutsch</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>L A Bradley</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>G E Palomaki</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>J E Haddow</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>M Piper</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>N Calonge</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>W D Dotson</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>M P Douglas</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>und A O Berg</name>
          <firstNames/>
        </ReferenceAuthor>
      </authors>
      <volume>11</volume>
      <publicationYear>2009</publicationYear>
    </Reference>
    <Reference>
      <marker>[15]</marker>
      <title>Suggested Ontology for Pharmacogenomics (SO-Pharm): Modular Construction and Preliminary Testing“,</title>
      <authors>
        <ReferenceAuthor>
          <name>A Coulet</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>M Smaïl-Tabbone</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>A Napoli</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>und M-D Devignes</name>
          <firstNames/>
        </ReferenceAuthor>
      </authors>
      <publicationYear>2006</publicationYear>
    </Reference>
    <Reference>
      <marker>[16]</marker>
      <title>The Sequence Ontology: a tool for the unification of genome annotations“,</title>
      <authors>
        <ReferenceAuthor>
          <name>K Eilbeck</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>S E Lewis</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>C J Mungall</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>M Yandell</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>L Stein</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>R Durbin</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>und M Ashburner</name>
          <firstNames/>
        </ReferenceAuthor>
      </authors>
      <volume>6</volume>
      <publicationYear>2005</publicationYear>
    </Reference>
    <Reference>
      <marker>[18]</marker>
      <title>Feasibility of incorporating genomic knowledge into electronic medical records for pharmacogenomic clinical decision support“,</title>
      <authors>
        <ReferenceAuthor>
          <name>C L Overby</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>P Tarczy-Hornoch</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>J I Hoath</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>I J Kalet</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>und D L Veenstra</name>
          <firstNames/>
        </ReferenceAuthor>
      </authors>
      <volume>11</volume>
      <publicationYear></publicationYear>
    </Reference>
    <Reference>
      <marker>[20]</marker>
      <title>Fuzzy Arden Syntax: A fuzzy programming language for medicine“,</title>
      <authors>
        <ReferenceAuthor>
          <name>T Vetterlein</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>H Mandl</name>
          <firstNames/>
        </ReferenceAuthor>
        <ReferenceAuthor>
          <name>und K-P Adlassnig</name>
          <firstNames/>
        </ReferenceAuthor>
      </authors>
      <volume>49</volume>
      <publicationYear>2010</publicationYear>
    </Reference>
    <Reference>
      <marker>[22]</marker>
      <title>Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success“,</title>
      <authors>
        <ReferenceAuthor>
          <name>K Kawamoto</name>
          <firstNames/>
        </ReferenceAuthor>
      </authors>
      <volume>330</volume>
      <publicationYear>2005</publicationYear>
    </Reference>
  </references>
</Publication>